RxDoctor Payments Data

James Lin, MD

Anesthesiology · Thousand Oaks, CANPI 1821009580

Payments from drug & device makers

$16,916in general payments, 2019–2025

Across 805 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Medtronic$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • Collegium Pharmaceutical, Inc.$1K
  • Lumenis BE Inc$1K
  • Relievant Medsystems, Inc.$1K
  • plus $8K from 45 others

What the payments were for

  • Travel & lodging$6144%
  • Food & beverage$16,28096%
  • Education$210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,916 in reported general payments places this provider in the 95th percentile of 5,717 anesthesiology providers in California.

See all anesthesiology providers in California

Medicare billing

Part B allowed, 2024
$1,015,983
Medicare patients
640
Services billed
11,652

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant36$57,743
RelistorMethylnaltrexone Bromide25$57,578
Xtampza ErOxycodone Myristate27$25,807
Aimovig AutoinjectorErenumab-Aooe26$20,166
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen563$13,549
ZtlidoLidocaine24$13,103
OxycontinOxycodone Hcl23$11,899
GraliseGabapentin14$11,857
MovantikNaloxegol Oxalate14$8,024
Emgality PenGalcanezumab-Gnlm12$7,786
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen216$7,384
SymproicNaldemedine Tosylate13$5,642
Lidocaine48$5,218
Diclofenac Sodium48$5,014
Fentanyl29$4,835

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy$2,200$57,74336 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$1,433$57,57825 claims
Collegium Pharmaceutical, Inc.Xtampza Er$1,410$25,80727 claims
Scilex Pharmaceuticals Inc.Ztlido$578$13,10324 claims
Almatica Pharma LLCGralise$141$11,85714 claims
Redhill Biopharma Inc.Movantik$63$8,02414 claims
Hikma Pharmaceuticals USABuprenorphine Hcl, Morphine Sulfate$73$1,96981 claims
Upsher-smith Laboratories LLCTopiramate$57$24321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,717 anesthesiology providers in California.

Other anesthesiology in Thousand Oaks

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →